Opus Genetics, Inc.
OPGx-LCA5
Countdown
633days
Approval decision · ~ Mar 31, 2028 estimated
What's at stake
A final FDA approval decision on OPGx-LCA5 for its lead indication is expected ~ Mar 31, 2028.
Primary source
· SEC 8-K
verified 13h ago
“a fourth tranche of $10 million will be available, (a) at the Company’s option, if the FDA Approval Date for OPGx-LCA5 has occurred ... on or prior to March 31, 2028.”